Especially in the setting of multiple neuroendocrine tumours, such as in the Multiple Endocrine Neoplasia Type 1 (MEN1) syndrome, expression analysis of glucagon, insulin, gastrin and pancreatic polypeptide allows identification of which one is the tumour responsible for a hormonal syndrome. This evidence concerns the gene INS and multiple endocrine neoplasia type 1.